IL6R and B-cell acute lymphoblastic leukemia: In addition, there is another FDA approved treatment for patients with arthritis and B cell acute lymphoblastic leukemia under CAR-T therapy, Tocilizumab, which recognizes IL-6R and disrupts the signaling cascade.